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Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1 or CD31) is thought to be a vascular-specific protein, but its
function has not been clearly defined. Here, we demonstrate by using confocal immunofluorescence microscopy that
PECAM-1 is first detected in the mouse blastocyst, which contains no vascular cells, and its expression is restricted to the
pluripotent inner cell mass (ICM) cells. Expression is localized to cell–cell borders of the ICM and is detected at the very
first signs of blastocoel formation. Consistent with these observations is that embryonic transcripts of PECAM-1 mRNA,
as detected by RT-PCR, greatly increase during the morula-to-blastocyst transition and seven of the eight known
alternatively spliced isoforms of PECAM-1 are expressed in the blastocyst. The synthesis of PECAM-1 is independent of
compaction, cytokinesis, and DNA replication, as it is detected in embryos that are chronologically at the blastocyst stage
following culture of 8-cell embryos in Ca21-free medium, or medium containing cytochalasin D or aphidicolin, respectively.
y the late blastocyst stage, PECAM-1 expression is restricted to the pluripotent epiblast, at which point it has a mutually
xclusive expression pattern to that of type IV collagen, a basement membrane marker. The reduction in PECAM-1
ranscripts in retinoic acid-induced differentiation of F9 teratocarcinoma cells, a model of epiblast-to-primitive endoderm
ifferentiation, confirmed the epiblast-specific expression of PECAM-1. By the egg cylinder stage of development, at which
oint the epiblast is no longer pluripotent, PECAM-1 is not detected. This ICM-specific pattern of expression suggests a
ovel developmental role of PECAM-1 that is independent of its function in vascular ontogeny. © 2001 Academic Press
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One of the first cellular differentiation events in the
mouse embryo occurs during the last day of preimplanta-
tion development as the morula transforms into the blas-
tocyst approximately 3.5 days post coitum (dpc). The outer
cells of the 32-cell morula become a fluid-transporting
epithelium, the trophectoderm (TE), that is responsible for
the formation of the blastocoel, the fluid-filled cavity of the
blastocyst (reviewed in Fleming et al., 1998). The inner cells
of the morula become the inner cell mass (ICM) cells of the
blastocyst. These pluripotent cells give rise to all tissues of
the embryo proper and to extraembryonic tissues. They are
1 To whom correspondence should be addressed. Fax: (215) 590-
g5454. E-mail: sbaldwin@mail.med.upenn.edu.
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All rights of reproduction in any form reserved.ot totipotent, however, like their precursor cells of the
orula that can contribute to the TE and its placental
erivatives (Gardner and Nichols, 1991). This suggests that
developmental signal has occurred that differentiates the
otipotent cells of the morula from the pluripotent cells of
he ICM. The initiation of ICM-localized transcription of
he genes FGF4, UTF1, and osteopontin may reflect such a
ignal (Botquin et al., 1998; Niswander and Martin, 1992;
kuda et al., 1998).
By 4.5 dpc, the blastocyst begins to implant in the uterine
all. At this point, the outer cells of the ICM that are in
ontact with the blastocoel differentiate into the primitive
ndoderm; these cells contribute exclusively to extraem-
ryonic lineages. The remaining ICM cells are classified as
he epiblast or primitive ectoderm, and remain pluripotent,
iving rise to the embryo proper and the germ cells, as well
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318 Robson et al.as contributing to components of the extraembryonic tis-
sues. From 4.5 to 5.5 dpc, the epiblast transforms from a
solid ball of rounded cells into cuboidal/columnar cells that
form the egg cylinder (see Kaufman and Bard, 1999 for
summary of cell fates). A molecular switch in the cells of
the epiblast appears to have occurred during this transition
from the late blastocyst to the early egg cylinder as these
cells lose their ability to colonize the blastocyst and to form
embryonic stem (ES) cells (Gardner and Brook, 1997).
Despite the importance of the ICM/epiblast in early
mouse development and the potential application of its in
vitro counterpart, the ES cell, little is known about the
molecular characteristics of this cell population. The tran-
scription factors Oct-4 and Sox-2 play a role in coordinating
the ICM-specific expression of UTF1, FGF4, and osteopon-
in (Botquin et al., 1998; Nishimoto et al., 1999; Yuan et al.,
995), but both of these transcription factors are also
xpressed prior to blastocyst formation (Scho¨ler et al., 1989;
obin Lovell-Badge, personal communication). Thus, their
xpression alone is not sufficient for ICM-specific gene
ranscription and further work is clearly required to under-
tand ICM-restricted gene expression patterns.
Molecules involved in cell–cell and cell–matrix interac-
ions are presumably important in defining and maintain-
ng the properties of the ICM and directing its future
ifferentiation (Damsky et al., 1993). The early embryonic
lethality due to the arrest of ICM differentiation in the b1
integrin and laminin g1-null mice emphasizes the impor-
ance of such interactions at these formative stages (Smyth
t al., 1999; Stephens et al., 1995). Nevertheless, no ICM-
pecific cell adhesion or membrane receptor molecules
ave been identified to date.
Platelet/endothelial cell adhesion molecule-1 (PECAM-
)—also known as CD31—is a plasma membrane-spanning
olecule that contains six Ig-like extracellular domains, a
hort transmembrane region, and a complex cytoplasmic
omain (Albelda et al., 1990; Newman et al., 1990). The
xtracellular domains are capable of forming both ho-
ophilic and heterophilic interactions with molecules on
FIG. 1. Developmental profile by RT-PCR of PECAM-1 mRNA e
cDNA from the oocyte through to the blastocyst are shown after 2
GAPDH control amplified for 30 cycles (bottom). Volumes repres
displayed using the inverted, ethidium bromide-stained images ofeighboring cells (DeLisser et al., 1994). The cytoplasmic m
Copyright © 2001 by Academic Press. All rightomain is derived from seven exons, and alternative splic-
ng of three of these can give rise to eight isoforms of
ssion in the preimplantation embryo. Relative levels of PECAM-1
p) and 32 (middle) rounds of amplification. This is compared to a
g embryo equivalent amounts of the amplification reactions are
els.xpre
9 (toFIG. 2. Immunofluorescence detection of PECAM-1 in the blasto-
cyst. A DIC image shows the morphology of a blastocyst (A) with the
location of the polar trophectoderm (polar TE), the mural trophecto-
derm (mural TE), the inner cell mass (ICM), and the blastocoel cavity
indicated. Confocal images of blastocysts immunostained with
Mec13.3, a monoclonal antibody to mouse PECAM-1 (B and D), and
with the 2° antibody alone (C) as a negative control. (B, D) Images of
the same blastocyst but at different planes on the Z-axis: (B) through
the center; (D) nearer the surface of the embryo and hence the
blastocoel cavity is not clearly visible. The structure indicated by the
asterisk (*) is a result of an in-folding of the mural TE into the
blastocoel during the mounting process. All images are of equalagnification and the scale bar represents 25 mm.
s of reproduction in any form reserved.
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319ICM-Specific PECAM-1 Expressionthe postgastrulation embryo, expression of PECAM-1 is
primarily restricted to cells of the vasculature, e.g., endo-
thelial cells, monocytes, neutrophils, platelets, and particu-
lar T-cell subsets. The first appearance of PECAM-1 in the
postgastrulation mouse embryo is on newly forming endo-
thelial cells in the embryonic yolk sac (embryonic day 7.5)
and later in the embryo proper (Baldwin et al., 1994; Vecchi
t al., 1994).
PECAM-1 is implicated in several vascular-specific func-
ions (for a review of the biology of PECAM-1 see DeLisser
t al., 1997a), and yet a precise role for PECAM-1 in any of
hese functions remains elusive. While initially character-
zed as a cell adhesion molecule, recent reports also suggest
role in signal transduction as the cytoplasmic domain can
ind to a number of signaling molecules, including SHP-2,
b-catenin, and g-catenin (Ilan et al., 2000; Jackson et al.,
997; Pumphrey et al., 1999). Thus, there is substantial
vidence that PECAM-1 plays a role in both cell adhesion
nd signal transduction within the vascular compartment.
We report here the temporal and spatial pattern of
ECAM-1 expression in the preimplantation mouse em-
ryo. The protein is first detected in the blastocyst and its
xpression is restricted to the ICM cells. At 4.5 dpc, its
xpression is limited to the epiblast and, by 5.5 dpc, is no
onger detected in the embryo. PECAM-1 expression is
ndependent of compaction, cytokinesis, and DNA replica-
ion. Furthermore, PECAM-1 mRNA is detected in the
orula, i.e., just prior to detection of PECAM-1 protein, and
even of the eight alternatively spliced isoforms of
ECAM-1 mRNA are present in the blastocyst. These
FIG. 3. Developmental profile of PECAM-1 protein expression in
stained embryos (Mec13.3 1° antibody) at progressive stages of m
morula is shown stained with 2° antibody alone (J). PECAM-1 staini
(*) formation (G, indicated by arrowheads). ICM-specific expression
magnification and the scale bar represents 25 mm.esults define PECAM-1 as the first cell adhesion molecule
Copyright © 2001 by Academic Press. All righto be ICM-specific and suggest a potential role for this
olecule prior to vascular differentiation.
MATERIALS AND METHODS
Embryo Collection and Culture
All embryos were derived from superovulated CF-1 mice (Har-
lan) mated to B6D2F1/J males (Jackson Laboratory). Embryos were
collected in bicarbonate-free MEM media (in which bicarbonate
was replaced with 25 mM Hepes, pH 7.4; Life Technologies)
containing 3 mg/ml polyvinylpyrrolidone (PVP). Embryos were
cultured in 50-ml drops of KSOM containing 0.53 essential and
nonessential amino acids (Life Technologies) under paraffin oil in
an atmosphere of 5% CO2 in air at 37°C as previously described (Ho
et al., 1995). Calcium-free KSOM containing amino acids was
prepared by omitting the CaCl2. To inhibit cytokinesis or DNA
synthesis, embryos were cultured in KSOM containing 0.5 mg/ml
ytochalasin D (Sigma) or 2.5 mg/ml aphidicolin (Sigma), respec-
tively. For all experiments, at least 10 embryos were used per data
point.
Cell Culture
F9 teratocarcinoma cells (ATCC) were cultured in DMEM media
with 10% FBS and antibiotic on 90-mm tissue culture dishes
coated with 0.1% gelatin. For immunofluorescence, cells were
grown on gelatin-coated glass coverslips prior to fixation. Total
RNA was isolated from F9 cells cultured for 0, 25.5, 49, 72.5, and
preimplantation embryo. Confocal images of PECAM-1 immuno-
preimplantation development (A–I). For a background control, a
cell–cell borders becomes evident at the initial stages of blastocoel
ly increases as the blastocyst expands (H, I). All images are of equalthe
ouse
ng at
rapid96 h in 1 mM retinoic acid using an RNeasy Mini kit (Qiagen).
s of reproduction in any form reserved.
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320 Robson et al.Immunocytochemistry and Confocal Microscopy
The zona pellucida was first removed by a brief treatment with
acid Tyrode’s solution. Embryos were briefly washed in phosphate-
buffered saline containing 3 mg/ml PVP (PBS/PVP) and fixed in
2.5% paraformaldehyde (PFA) in PBS for 15 min at room tempera-
ture. Fixed embryos were stored at 4°C in PBS/PVP. All subsequent
steps involved washing the embryos through microdrops held at
room temperature in a humidified chamber. Initially, embryos
were placed in blocking solution (0.1% BSA, 0.01% Tween 20, PBS)
for 15 min; this solution was used in all subsequent steps. The
embryos were incubated for 60 min in 1.5 mg/ml Mec 13.3
(Pharmingen), which is a monoclonal antibody that recognizes an
extracellular domain of PECAM-1, washed three times (15 min for
each wash), and incubated for 1 h with the appropriately conjugated
goat anti-rat IgG (Jackson ImmunoResearch Laboratories), followed
by a final three washes, each for 15 min. Type IV collagen staining
followed a similar procedure but using a 1/500 dilution of a rabbit
anti-mouse polyclonal antibody (Chemicon).
Vectashield mounting solution (Vector Laboratories) was used to
mount the embryos onto slides. Nuclear staining was accom-
plished by adding Vectashield with DAPI to total 1/10 the mount-
ing solution volume. To maintain blastocyst structure, the em-
bryos were passed through increasing concentrations of mounting
solution (25, 50, and 75%, diluted with PBS/PVP) for 15–30 min.
Following transfer to 100% mounting solution, the embryos were
then placed on the slide in ;5 ml. Coverslips were placed over the
mbryos onto four spots of Vaseline and sealed with nail polish.
luorescence was detected on a Leica SP laser-scanning confocal
icroscope.
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR)
Total RNA was isolated from 95 oocytes, 56 one-cell, 200
two-cell, 107 uncompacted eight-cell, 160 early morula (76 h post
hCG), 66 late morula (85 h post hCG), and 143 expanded blasto-
cysts by using Qiagen’s RNeasy Mini Kit. Sigma’s enhanced Avian
RT-PCR kit was used for reverse transcription primed with
oligo(dT). In each amplification reaction, cDNA representative of
two embryo equivalents was used and equivalent amounts of the
reactions were compared by gel electrophoresis. At these early
stages of development, embryo equivalents are the most suitable
and preferred method of comparison since there is no growth
between the one-cell and blastocyst stages. Nevertheless, the
relative amounts of GAPDH mRNA were also included to insure
consistency in RNA isolation and in the reverse transcription
reaction. Also, for consistency, RNAs from all the developmental
time points sampled were purified at the same time from frozen,
pooled embryos.
The standard primer set for PECAM-1 amplification consisted of
a 59 primer to exon 4 (59-AGGGGACCAGCTGCACATTAGG-39)
and a 39 primer to exon 6 (59-AGGCCGCTTCTCTTGACCACTT-
9); when annealed at 58°C, these primers result in a single 452-bp
mplification product. To delineate the alternatively spliced cyto-
lasmic domain isoforms of PECAM-1, primers were designed to
pan exon–exon junctions in the region of alternative splicing. The
equences of these primers were as follows with numbers in
arentheses referring to the corresponding exon junction and U and
referring to 59 and 39 primers, respectively: ACAGCCATTACG-
TTATG (11/12U), AACAGCCATTACGACCC (11/13U), CTTC-
GTTCTTTGGTGA (13/16L), CTTCCGTTCTAGGGTCG (14/
6L), and CCTTCCGTTCTAGAGTATC (15/16L). The primer sets t
Copyright © 2001 by Academic Press. All rightps) and corresponding annealing temperatures were as follows:
s1 5 11/12U and 15/16L at 62°C; ps2 5 11/13U and 15/16L at
2°C; ps3 5 11/12U and 14/16L at 60°C; ps4 5 11/13U and 14/16L
t 58°C; ps5 5 11/12U and 13/16L at 60°C; ps6 5 11/13U and
3/16L at 58°C. Specificity of these primer sets was confirmed by
esting each on all eight cDNA isoforms. Seven of the eight
soforms’ cDNAs had previously been cloned (Baldwin et al., 1994)
nd the eighth (D12,14) was a gift from Nader Sheibani (Washington
niversity, St. Louis, MO). A total of 3.2 embryo equivalents of
lastocyst cDNA were used as template for each set of primers and
mplification was for 40 cycles. The appropriate cDNAs were used
s positive controls and water as a negative control. The identity of
he D12, D14, D15, D12/14, D14/15, and the full-length amplifica-
ion products from the blastocyst were confirmed by sequencing.
GAPDH 59 (GCATGGCCTTCCGTGTTCCT) and 39 (CCCT-
TTGCTGTAGCCGTATTCAT) primers yielded a single product
f 282 bp at 58°C; Oct-4 59 (ACCGCCCCAATGCCGTGAAGTT)
nd 39 (TGGGGGCAGAGGAAAGGATACAGC) primers yielded
single product of 593 bp at 62°C; Sox-2 59 (GCTCACGGCGCG-
CACAGATG) and 39 (CCAGTTCGCAGTCCAGCCCTCACA)
rimers yielded a single product of 412 bp at 62°C; tPA 59
TTGGGCAGAACATACAGGGTGGTC) and 39 (CTGGCATG-
ATCGTGGAGGTCTT) primers yielded a single product of 414
p at 62°C. The identity of the Oct-4, Sox-2, and PECAM-1
mplicons from the undifferentiated F9 cells and the tPA and
APDH amplicons from the differentiated F9s after 4 days of RA
reatment were all confirmed by sequencing. All amplification
eactions were performed on a Gradient Robocycler (Stratagene) by
sing Taq DNA polymerase (Life Technologies). All reactions used
n extension temperature of 72°C for 1 min, a denaturation
emperature of 94°C for 45 s, and the above-mentioned annealing
emperatures for 45 s. The number of cycles for each reaction is
iven in Results.
RESULTS
Temporal Pattern of PECAM-1 mRNA Expression
in Preimplantation Development
PECAM-1 transcripts had previously been identified in
ES cells (Vittet et al., 1996). Since ES cells are derived from
nd maintain the same pluripotency as the ICM (Bradley et
l., 1984; Evans and Kaufman, 1981; Martin, 1981), we
nticipated that PECAM-1 mRNA would also be found in
he blastocyst. A primer set that spanned exon boundaries
as designed for use in RT-PCR analysis to amplify a single
roduct corresponding to the extracellular domain of
ECAM-1. Amplification of blastocyst cDNA using this
rimer set produced a single amplicon of the appropriate
ize (see blastocyst lane in Fig. 1). The sequencing results
rom this amplicon confirmed our prediction that
ECAM-1 mRNA was present in the blastocyst.
We extended this RT-PCR analysis to earlier stages of
evelopment to ascertain whether PECAM-1 was expressed
rior to blastocyst formation. Total RNA isolated from
ocytes and preimplantation embryos at different stages of
evelopment were analyzed. The results from this analysis
ndicated that PECAM-1 transcript was most abundant in
he blastocyst. After 29 cycles of amplification, PECAM-1
ranscript was only observed in the blastocyst (Fig. 1). With
s of reproduction in any form reserved.
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321ICM-Specific PECAM-1 Expressionfurther amplification (32 cycles), PECAM-1 expression
could be detected in the late morula. The increase in
mRNA from the morula to the blastocyst may in fact be
more pronounced than represented here since the early
blastocoel is undetectable under the dissecting microscope
and embryos undergoing initial blastocoel formation may
have been included with the late morula stage embryos
during embryo collection. This did occur for similar embryo
collections used for immunostaining (see below).
Maternally derived transcripts, which were apparent in
the oocyte after 32 cycles of amplification, were essentially
degraded by the two-cell stage. The destruction of maternal
PECAM-1 transcripts is similar to the widespread destruc-
tion of most maternal mRNAs that occurs between the
oocyte and two-cell stage (Schultz, 1993 and references
therein). There appeared to be a slight increase at the
eight-cell stage, but the largest increase in PECAM tran-
script was seen from the late morula-to-blastocyst transi-
tion. This PCR was repeated a total of four times with
similar results, therefore these findings are not the result of
PCR artifacts.
PECAM-1 Protein Expression Is Restricted
to the ICM
There are three anatomically identifiable cell types in the
blastocyst: the mural trophectoderm (TE not in contact
with the ICM), the polar trophectoderm (TE in contact with
the ICM), and the ICM (Fig. 2A). We therefore employed
laser-scanning confocal microscopy using a monoclonal
antibody to an extracellular domain of murine PECAM-1
(Mec13.3) to localize PECAM-1 expression in the blasto-
cyst. PECAM-1 expression was detected in the ICM, and
staining was specific to cell–cell borders (Fig. 2B). In strik-
ing contrast, the mural TE was negative for PECAM-1 (Fig.
2D). The polar TE also appeared to be negative for
PECAM-1, at least at cell surfaces other than TE cell–ICM
cell junctions. It could not be established whether the
staining at polar TE/ICM borders was solely due to ICM-
specific expression.
When initially optimizing the immunofluorescence pro-
cedure, we also used another PECAM-1 antibody, mAb 390
(Baldwin et al., 1994). We observed a similar signal to that
of Mec13.3 when shorter fixation times (1–7 min) were used
(data not shown). These results provided an independent
confirmation of PECAM-1 expression in the blastocyst.
Since the epitope for this antibody was lost upon longer
fixation times, the Mec13.3 antibody was used in all sub-
sequent experiments.
Temporal Pattern of PECAM-1 Protein Expression
during Preimplantation Development
The observations that PECAM-1 was restricted to the
ICM and its transcripts substantially increased from the
morula to blastocyst transition led us to investigate
PECAM-1 protein localization throughout preimplantation
Copyright © 2001 by Academic Press. All rightevelopment. Accordingly, we analyzed PECAM-1 expres-
ion by laser-scanning confocal immunohistochemistry on
ocytes and embryos at different developmental stages. In
hese experiments, 10–20 oocytes/embryos were analyzed
t each developmental stage.
PECAM-1 protein staining in oocytes, one-cell, two-
ell, four-cell, eight-cell, and morula (16- to 32-cell)
mbryos (Figs. 3A–3F) all had levels of fluorescence
imilar to that of the negative controls (i.e., embryos at
he same stage of development but stained with the 2°
ntibody alone; see Fig. 3J as an example). There was no
etectable cell– cell border staining of PECAM-1 at these
evelopmental stages. Strikingly, PECAM-1 staining at
ell– cell borders of the ICM appeared at the very initial
tages of blastocoel formation, i.e., as soon as this cavity
ecame detectable by confocal microscopy (Fig. 3G).
ndeed, a number of embryos at this stage were initially
lassified as late morula, as the blastocoel was not
pparent under the dissecting microscope during embryo
ollection; the cavity only became visible when the
mbryos were examined by confocal microscopy. The
uorescence signal from PECAM-1 rapidly increased as
he blastocoel expanded in mid (Fig. 3H) and fully ex-
anded blastocysts (Fig. 3I).
Expression of PECAM-1 Is Not Directly Linked
to Compaction, Cytokinesis, or DNA Synthesis
The mechanism underlying the timing of blastocoel
formation in the mouse embryo still remains unclear.
There appears to be an intrinsic molecular clock controlling
blastocoel formation that is independent of the absolute
cell number, the number of cytokineses, the number of
DNA replicative cycles, and the nucleo-cytoplasmic ratio
(Dean and Rossant, 1984; Smith and McLaren, 1977; Surani
et al., 1980; Tarkowski and Wroblewska, 1967). To deter-
mine whether PECAM-1 localization to the cell–cell
borders of the ICM was also linked to this intrinsic mo-
lecular clock, we attempted to affect its expression by
independently altering compaction, cytokinesis, and DNA
synthesis.
Culturing uncompacted eight-cell embryos in Ca21-free
media disrupts compaction, which is a Ca21-dependent,
E-cadherin-mediated event (Vestweber and Kemler, 1985)
that occurs at the eight-cell stage. Embryos treated as such
continue to divide but do not compact or form a blastocoel.
In these experiments, when control embryos (i.e., eight-cell
embryos cultured in Ca21-containing media) had formed
expanded blastocysts, all embryos in both groups were
analyzed for PECAM-1 expression. The embryos cultured in
Ca21-free media, although not forming any blastocoel, did
have localized PECAM-1 staining at cell–cell borders (Fig.
4B), although not all cells were PECAM-1-positive.
To ascertain whether PECAM-1 expression was linked to
cell division, early morula (16-cell) were cultured in cy-
tochalasin D. This drug inhibits cytokinesis and blastocoel
formation, but not karyokinesis; the temporal sequence of
s of reproduction in any form reserved.
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322 Robson et al.the treated embryo’s molecular development remains the
same as that of untreated cells (Pratt et al., 1981). All
embryos were analyzed for PECAM-1 localization after
control embryos (i.e., early morula cultured without cy-
tochalasin D) formed fully expanded blastocysts. PECAM-1
staining, although relatively less than control embryos, was
evident on some but not all of the large multinucleated
cells of the cytochalasin D-treated embryos (Fig. 4C).
To block DNA synthesis, early morula (16-cell) were
cultured in aphidicolin. Embryos treated as such form
blastocysts with fewer cells (Dean and Rossant, 1984). Since
prolonged treatment with aphidicolin results in embryo
death (Dean and Rossant, 1984), the embryos were cultured
in the presence of aphidicolin for 9 h, which is long enough
to prevent at least one cycle of DNA replication, prior to
transfer to aphidicolin-free medium. The embryos were
then cultured and analyzed for PECAM-1 protein expres-
sion at a time when control embryos (i.e., early morula
FIG. 4. PECAM-1 expression is not dependent on compaction,
cytokinesis, or DNA synthesis. Confocal images of PECAM-1-
immunostained embryos. (A) Control blastocyst derived from
cultured eight-cell embryo. (B) Embryo cultured in Ca21-free media
from the uncompacted eight-cell stage. (C) Embryo cultured in
media containing 0.5 mg/ml cytochalasin D from the uncompacted
eight-cell stage. (D) Shortly after compaction, embryos were cul-
tured for 9 h in medium containing 2.5 mg/ml of aphidicolin. The
embryos were then transferred to aphidicolin-free media and cul-
tured until blastocyst formation. These blastocysts, which were
also stained with DAPI (green nuclei), clearly contain fewer cells
then the control embryos. All images are of equal magnification
and the scale bar represents 25 mm.cultured without aphidicolin) formed fully expanded blas-
Copyright © 2001 by Academic Press. All rightocysts. As expected, the aphidicolin-treated embryos
ormed blastocysts with fewer cells (;23 cells per blasto-
yst) compared to the control embryos (;35 cells per
lastocyst). Nevertheless, PECAM-1 in aphidicolin-treated
mbryos localized to cell–cell borders specific to the inner
ell mass (Fig. 4D).
Alternatively Spliced Isoforms of PECAM-1 Present
in the Blastocyst
The cytoplasmic, C-terminal end of the PECAM-1 mole-
cule is 120 amino acids long and spans 8 exons, 3 of which
are alternatively spliced (exons 12, 14, and 15) in the
postgastrulation mouse embryo (Baldwin et al., 1994; Shei-
bani et al., 1999). To determine the alternative splicing
combinations that were present in the ICM of the blasto-
cyst, we designed six primer sets that could distinguish all
eight isoforms (see Materials and Methods for details) and
used these in RT-PCR analysis of blastocyst total RNA.
Seven of the eight known spliced isoforms were observed,
only the D12,15 isoform was not detected (Fig. 5). Although
this method was not directly designed for quantitation,
comparison of isoform amplification from the blastocyst to
that from plasmid templates suggest that D14,15 and D15
re the most abundant isoforms, which is consistent with
hat observed in endothelial cells (Sheibani et al., 1999).
Peri- and Early Postimplantation Expression
of PECAM-1
As PECAM-1 expression was restricted to the undifferen-
tiated cells (ICM) of the 3.5 dpc blastocyst and was not
detected in the differentiated cells of the TE, we were
interested in seeing whether PECAM-1 expression re-
mained restricted to the undifferentiated cell population
upon further development of the embryo. By 4.5 dpc, the
primitive endoderm, the cell layer in contact with the
blastocoel, has differentiated from the ICM. The remainder
of cells from the ICM (i.e., the epiblast/primitive ectoderm)
stay undifferentiated/pluripotent. Therefore, we analyzed
PECAM-1 protein expression in blastocysts that had been
rigorously flushed from the uterine wall at embryonic day
4.5. In these embryos, PECAM-1 expression appeared to be
restricted to the epiblast (Fig. 6A), since a single layer of
PECAM-negative cells (the primitive endoderm) was
present between the cavity and the PECAM-positive cells
appropriately located to be defined as the epiblast.
To confirm that PECAM-1 was localized to the epiblast,
we tried dual-labeling experiments using the PECAM-1
antibody in combination with antibodies to other blasto-
cyst cell-type-specific antigens. Dual labeling with SSEA-1
or Troma-1 was unsuccessful. However, a basement mem-
brane is located between the mural TE and the blastocoel
(Thorsteinsdo´ttir, 1992), therefore we pursued dual immu-
nostaining with type IV collagen, a basement membrane
collagen. Confocal images from embryos stained only for
Type IV collagen revealed an extensive basement mem-
s of reproduction in any form reserved.
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323ICM-Specific PECAM-1 Expressionbrane with a circular patch of cells distinctly devoid of type
IV collagen in the location of the epiblast (Fig. 6B). From
another harvest of 4.5 dpc embryos, dual-staining experi-
ments for PECAM-1 and type IV collagen clearly indicated
a mutually exclusive expression pattern between these two
proteins (Figs. 6D–6F). From these same embryos, nuclear
staining by DAPI suggested a PECAM-1-negative cell layer
between the epiblast and the blastocoel, a location consis-
tent with the primitive endoderm (Fig. 6C).
To confirm that PECAM-1 was restricted to the epiblast
and not found in the primitive endoderm, we utilized the
retinoic acid-induced differentiation of ICM/epiblast-like
F9 teratocarcinoma cells into primitive endoderm-like cells
(Robertson, 1987). First, we confirmed by immunostaining
that undifferentiated F9 cells contain PECAM-1 (Fig. 7A);
PECAM-1 is clearly found localized to the cell–cell sites of
contact. F9 cells were then induced to differentiate with 1
mM retinoic acid over a 4-day period from which we isolated
RNA every 24 h. Transcripts of markers of the undifferen-
tiated cell type, such as Oct-4 and Sox-2, would be expected
to decrease upon differentiation, and markers of differentia-
tion, such as tPA, expected to increase (Behrendtsen et al.,
1995). RT-PCR analysis of this RNA clearly indicated
PECAM-1 levels dropped to almost undetectable levels in
the differentiated cells after 4 days of RA induction (Fig. 7B).
Primitive endoderm-like cellular differentiation clearly oc-
curred as tPA transcripts appeared and Sox-2 transcripts
disappeared over the 4 days of differentiation (Fig. 7B). Oct-4
transcript levels decreased gradually, probably reflecting
the quantitative nature of this transcription factor in direct-
FIG. 5. PECAM-1 alternatively spliced isoforms present in the bl
different isoforms of PECAM-1 were used in RT-PCR analysis of bla
(c#) and negative control water (w). The inverted, ethidium bromi
ecognizes the wt (c1) and D14 (c2) isoforms, both of which are pr
isoforms, both of which are present in the blastocyst. (C) ps3 reco
recognizes the D12,15 isoform (c6), which is not present in the blast
blastocyst. (F) ps6 recognizes the D12,14,15 isoform (c8), which is pr
the alternatively spliced exons in white.ing self-renewal or differentiation (Niwa et al., 2000).
Copyright © 2001 by Academic Press. All rightAt the 5.5 dpc time point in development, the mouse
mbryo is well implanted in the uterine wall and is sur-
ounded by a large mass of decidual tissue. The epiblast
ells are no longer rounded and pluripotent, but are colum-
ar in shape. We determined whether PECAM-1 was detect-
ble by immunostaining paraffin-embedded sections. The
mbryo at this stage was completely negative for PECAM-1
Fig. 8C), although it was found in certain cells of the
ecidual mass (Fig. 8B). The decidual mass staining, most
ikely the result of endothelial cells from maternally de-
ived capillaries, was useful as a positive control. These
esults indicate that PECAM-1 expression disappears from
he cells of the epiblast in their transition from their
ounded morphology in the 4.5-day embryo to their colum-
ar morphology in the 5.5-day egg cylinder.
DISCUSSION
In this report, we have characterized the expression of the
first cell adhesion molecule—PECAM-1—that is specific to
the ICM/epiblast of the mouse blastocyst. PECAM-1 ex-
pression is restricted to cell–cell borders of the ICM at the
first visible signs of blastocoel formation, is subsequently
confined to the epiblast at peri-implantation, and is then
undetectable in the egg cylinder.
PECAM-1 was previously thought to be vascular-specific,
first appearing in newly forming endothelial cells of the
yolk sac at embryonic day 7.25, approximately 2.75 days
after implantation (Baldwin et al., 1994; Drake and Flem-
yst. Six different primer sets (ps) designed to distinguish the eight
yst total RNA (bl). These were compared to positive control cDNA
ained image of the amplification products is shown here. (A) ps1
in the blastocyst. (B) ps2 recognizes the D12 (c3) and D12,14 (c4)
s the D15 isoform (c5), which is present in the blastocyst. (D) ps4
. (E) ps5 recognizes the D14,15 isoform (c7), which is present in the
t in the blastocyst. A schematic of the clones is shown below withastoc
stoc
de-st
esent
gnize
ocyst
esening, 2000). The first evidence that PECAM-1 expression
s of reproduction in any form reserved.
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324 Robson et al.might occur much earlier in development, prior to endothe-
lial cell differentiation, derives from previous work of ours
incorporating the 215,000- to 160-bp region (relative to the
transcription start site) of the mouse PECAM-1 gene driving
the expression of Cre recombinase (Terry et al., 1997).
hen such a transgenic mouse was crossed with a mouse
omologous for a conditional VCAM allele, the progeny
ffectively resulted in a nonconditional VCAM knockout,
uggesting that this transcriptionally active region of the
ECAM-1 gene drives expression of Cre in progenitor cells
f the embryo proper. In addition, another report recently
dentified PECAM-1 mRNA and protein in ES cells (Vittet
t al., 1996). While our studies were in progress, a report,
rimarily focused on the differentiation of ES cells into
ndothelial cells, briefly noted PECAM-1 expression in the
lastocyst without further defining cellular localization or
inetics of expression (Redick and Bautch, 1999).
Numerous cell types of the vasculature express PE-
AM-1: monocytes, neutrophils, platelets, particular B-cell
nd T-cell subsets, and endothelial cells. Although a precise
unction for PECAM-1 in these cells is still unknown, it has
otential roles in the inflammatory response (Muller et al.,
993; Wakelin et al., 1996), angiogenesis (DeLisser et al.,
997b; Matsumura et al., 1997; Yang et al., 1999), vasculo-
enesis (Baldwin et al., 1994), and some T-cell responses
Torimoto et al., 1992; Zehnder et al., 1995). PECAM-1-
eficient mice are viable but exhibit an abnormal migration
f leukocytes across vascular basement membranes (Dun-
an et al., 1999) and display a prolongation in bleeding time
Mahooti et al., 2000). The work reported here indicates
hat PECAM-1’s function is not restricted to the vascula-
ure, as the blastocyst develops a full 4 days prior to any
ascular formation. However, as evidenced from the null
ice, this expression is not essential for embryo viability.
PECAM-1-mediated cell adhesion is predominantly the
nteraction of its extracellular domains interacting with
ne another on neighboring cell surfaces (Sun et al., 2000;
ong et al., 2000) (i.e., homophilic adhesion). This is
hought to be due to a “diffusion trapping” mechanism (Sun
t al., 2000) whereby PECAM-1 diffuses within the plane of
he plasma membrane until it comes in contact with a
ECAM-1 molecule on a neighboring cell. In endothelial
ells in vivo, this results in the majority of PECAM-1
olecules accumulating at the cell–cell junctions between
eighboring endothelial cells, the luminal and basal endo-
helial cell surfaces having much fewer PECAM-1 mol-
cules (Albelda et al., 1991). Cell–cell contact in the ICM
overs the entire surface of each cell and concomitantly
ECAM-1 appears to be uniformly distributed across these
ell surfaces (as evidenced from our serial confocal scans
hrough the PECAM-1 immunostained ICMs), presumably
n homophilic interactions with PECAM-1 on neighboring
ells of the ICM.
PECAM-1 is also capable of trans-heterophilic interac-
ions (DeLisser et al., 1994; Yan et al., 1995). PECAM-1
immunostaining was apparent at the cell–cell borders be-
tween the ICM and polar TE but not at cell–cell junctions n
Copyright © 2001 by Academic Press. All rightetween adjacent polar trophectoderm cells (see Fig. 2B).
lthough we cannot rule out the possibility that PECAM-1
s expressed in the cells of the polar TE and exclusively
ocalized to the TE:ICM interface, the lack of PECAM-1 at
ell–cell junctions between neighboring cells of the polar
E suggests that this is not the case. Therefore, PECAM-1
taining at ICM-polar TE junctions is likely the result of
CM-derived PECAM-1 molecules interacting with a het-
rophilic ligand on the polar TE.
Recent work has begun to focus on the function of the
ytoplasmic domain of PECAM-1. Amino acid residues
urrounding two tyrosines located in exons 13 and 14
onform to immunoreceptor tyrosine-based activation mo-
ifs (ITAMs) and immunoreceptor tyrosine-based inhibition
otifs (ITIMs) (Newman, 1999; Pumphrey et al., 1999).
HP-1, SHP-2, SHIP, b-catenin, g-catenin, and phospho-
lipase C-g1 all are capable of association with the cytoplas-
mic domain of PECAM-1 (Ilan et al., 1999, 2000; Jackson et
al., 1997; Pumphrey et al., 1999). In the blastocyst
PECAM-1 may function through at least some of these
molecules as SHP-2, b-catenin, and g-catenin are all present
n the blastocyst (Ohsugi et al., 1997).
Exons 12, 14, and 15 are subject to alternative splicing
hich likely adds further complexity to the signaling func-
ion of PECAM-1 (Baldwin et al., 1994; Sheibani et al.,
999). The significance of PECAM-1 alternative splicing in
ny tissue is not understood though isoforms lacking exon
4 appear to favor homophilic binding and isoforms with
his exon favor heterophilic binding (Yan et al., 1995).
ifferential association of signaling molecules to particular
pliced isoforms of PECAM-1 have not been extensively
tudied. It appears, however, that exon 14 is required for
HP-2 binding (Wong et al., 2000). There does not appear to
e tissue specificity of individual isoforms as the majority
re found in all tissues that normally express PECAM-1
Sheibani et al., 1999). The blastocyst is no exception to this
s we identified seven of the eight potential isoforms. From
ur analysis the D15 and D14,15 isoforms appear to be the
ost abundant in the blastocyst. This abundent expression
f D15 in the undifferentiated cells of the ICM is intriguing
iven that an apparent dedifferentiation has been observed
hen the D15 isoform is stably transfected into an epithe-
ial cell line (Sheibani et al., 2000).
PECAM-1 expression in the early embryo, first detected
t the initial stages of ICM formation and disappearing in
he epiblast by the early egg cylinder, closely corresponds to
he pluripotency of these cells. Here we define pluripotency
s the ability to colonize the blastocyst and to form ES cells.
ells of both the ICM and early epiblast are capable of these
ctions but during the transition from late blastocyst to
arly egg cylinder this ability is lost (Brook and Gardner,
997; Gardner and Brook, 1997). This same transition is
arked by a morphological change from a solid ball of
ounded cells in the early epiblast into a columnar epithe-
ium in the egg cylinder epiblast. Contact with the base-
ent membrane is required for the survival of these colum-
ar epithelial cells (Coucouvanis and Martin, 1995). Our
s of reproduction in any form reserved.
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325ICM-Specific PECAM-1 Expressionwork here distinctly shows that the PECAM-1-positive,
rounded cells of the early epiblast lack any contact with the
basement membrane (Fig. 6F) and once the columnar epi-
thelial epiblast is formed PECAM-1 is no longer expressed
(Fig. 8C). Furthermore, PECAM-1 expression disappears
from F9 teratocarcinoma cells when these cells are induced
FIG. 6. Epiblast-specific staining of PECAM-1 in the 4.5-day
embryo. All panels are confocal images of 4.5-dpc embryos. (A) An
embryo immunostained for PECAM-1, (B) for type IV collagen, and
(C–F), all from the same embryo, for PECAM-1 and type IV
collagen. (C) The image from the Cy3 channel (PECAM-1) is
overlaid with the DAPI signal for nuclear staining. (D) Solely the
Cy3 channel, (E) the FITC (type IV collagen) channel, and (F) both
Cy3 and FITC channels. The PECAM-1-negative region in the
dashed area (A, C) represents the primitive endoderm. Images (A)
and (B) are of equal magnification and images (C–F) are of equal
magnification. The scale bars represent 25 mm.to differentiate into basement membrane-synthesizing p
Copyright © 2001 by Academic Press. All rightrimitive endoderm-like cells (Fig. 7B). As basement mem-
ranes are well known to be a source of differentiation
ignals (Gumbiner, 1996), it is possible that PECAM-1’s
rans-homophilic interactions prevent attachment to the
asement membrane and thereby interfere with potential
ifferentiation signals.
Another possible role for PECAM-1 in maintaining plu-
ipotency may involve its cytoplasmic domain, a region
hat apparently functions as an inhibitor and modulator of
ell signaling (Ilan et al., 1999; Newton-Nash and Newman,
999). Self-renewal of ES cells involves the binding of LIF to
he cell surface receptor gp130 and activation of STAT3
Ernst et al., 1999; Matsuda et al., 1999; Niwa et al., 1998).
Interestingly, the elimination of SHP-2 binding to gp130
enhanced ES cell self-renewal (Burdon et al., 1999). Thus
PECAM-1, with its ability to bind SHP-2, may act to
modulate SHP-2 binding to gp130.
PECAM-1 protein localizes to the cell–cell borders of the
ICM at the onset of blastocyst formation (Fig. 3G). This,
combined with the corresponding increase in PECAM-1
mRNA in the late morula/early blastocyst (Fig. 1) likely
indicates an increase in the rate of transcription from the
PECAM-1 gene, although at this juncture an increase in
mRNA stability cannot be excluded. The apparent induc-
tion of transcription is independent of compaction, cytoki-
nesis, and DNA synthesis, as inhibition of any one of these
processes does not prevent PECAM-1 expression. This
preimplantation expression pattern of PECAM-1 is likely
coordinated by ICM-specific transcription factors. Oct-4
and Sox-2 are important regulators of ICM-specific tran-
scription as both are involved in the ICM-specific expres-
sion of FGF4, UTF1, and osteopontin (Botquin et al., 1998;
Nishimoto et al., 1999; Yuan et al., 1995). However, there
ust be further complexity to this regulation as both Oct-4
nd Sox-2 are expressed prior to blastocyst formation but
he expression of FGF4, UTF1, and osteopontin, like that of
ECAM-1, only begin upon blastocyst formation. For the
ECAM-1 gene, there is indirect evidence from the
ECAM-1/Cre mice (mentioned above and in Terry et al.,
997) that the 15-kb 59 flanking region is sufficient to drive
CM expression of PECAM-1. Sequencing of this region,
hich is 85% complete, has yet to identify any potential
ox-2 or Oct-4 binding sites. This opens up the intriguing
ossibility that ICM-specific PECAM-1 expression is con-
rolled by an as yet undefined mechanism. PECAM-1 pro-
oter studies in F9 teratocarcinoma cells, which are cur-
ently in progress, will allow us to identify the mechanisms
nvolved in ICM-specific PECAM-1 transcription.
In summary, we have characterized the expression of
ECAM-1 in the preimplantation embryo. PECAM-1 was
reviously thought to be restricted to cells of the vascula-
ure, however, its ICM-specific expression now provides a
onvascular cell system to study its as yet unknown
unction. Furthermore, this is the first characterization of
n ICM-specific cell adhesion molecule in the mouse blas-
ocyst. Notwithstanding a potential role in maintaining
luripotency, PECAM-1’s expression pattern makes it a
s of reproduction in any form reserved.
F326 Robson et al.FIG. 7. PECAM-1 is found in undifferentiated but not in retinoic acid-induced differentiated F9 teratocarcinoma cells. (A) Undifferentiated
9 cells immunostained for PECAM-1. The scale bar represents 50 mm, the inset is a 2-fold magnification. (B) RT-PCR analysis of GAPDH,
Oct-4, Sox-2, PECAM-1, and tPA mRNA levels are shown at 24-h intervals over the span of 4 days of 1 mM retinoic acid treatment.
FIG. 8. PECAM-1 expression is not detected in the egg cylinder stage embryo at embryonic day 5.5. (A) A DIC image of a 5.5-dpc embryo
(enlarged in C) is shown embedded in the decidual mass. (B, C) Regions of (A) magnified 5-fold that have been immunostained with the
PECAM-1 antibody, Mec 13.3. The scale bar represents 250 mm.
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327ICM-Specific PECAM-1 Expressiongood marker of these cells, a practical aspect of which may
be the use of this cell surface antigen in cell sorting for
pluripotent cells. Future studies of PECAM-1 in the ICM
and in ES cells should yield novel insights into the biology
of these unique cells.
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